Gynecology, Obstetrics & Women’s Health Congress 2026 – London, UK

The 2nd World Congress on Gynecology, Obstetrics & Women’s Health (Gynecology 2027) will be held on September 22–24, 2027, in Barcelona, Spain, as a hybrid international congress, offering participants the flexibility to attend in person or online. The congress brings together gynecologists, obstetricians, physicians, researchers, academicians, midwives, healthcare professionals, and industry experts to exchange knowledge and explore the latest developments in gynecology, obstetrics, and women’s health.

The scientific program will cover key areas including maternal-fetal medicine, reproductive health, fertility and infertility, gynecologic oncology, reproductive endocrinology, minimally invasive gynecologic surgery, obstetric care, high-risk pregnancy, urogynecology, neonatal health, and emerging advances in women’s healthcare. Through keynote lectures, plenary sessions, invited talks, oral and poster presentations, and interactive discussions, participants will gain insights into current research, clinical practices, and innovative approaches.

Gynecology 2027 aims to foster global collaboration, professional networking, and meaningful scientific exchange among healthcare professionals worldwide. Whether joining onsite in Barcelona or virtually online, participants can present their research, connect with international experts, share clinical experiences, and exchange ideas that contribute to improving women’s health and healthcare outcomes.

Infertility is a complex medical condition affecting both men and women, often caused by hormonal imbalances, genetic factors, or underlying disorders such as polycystic ovary syndrome (PCOS) and endometriosis. PCOS disrupts ovulation, leading to irregular menstrual cycles and reduced fertility, while endometriosis causes inflammation and scarring, impairing reproductive function. Male factor infertility, commonly associated with low sperm count, poor motility, or abnormal morphology, requires thorough evaluation through semen analysis and hormone assessments. Accurate diagnosis through advanced imaging, laboratory tests, and genetic screening is essential for effective treatment planning.